Talha Badar: Optimizing Venetoclax Duration in AML

Miriam Mutebi: Thoughts From IARC 60 Conference at Lyon

OncoDaily Brings Sarcoma Experts Together at ASCO 2026

10 Must-Read Posts In GI Oncology This Week

Grand Rounds by OncoDaily: AI in Oncology Edition

Oncology News, Insights, Stories by OncoDaily

OncoDaily GU
Voices

OncoDaily GU - Follow for Curated Updates in Genitourinary Oncology

Eric Small
Voices

ASCO President Eric Small’s Message to the Global Community Ahead of the ASCO26

Yvonne-Awards-2026 - OncoDaily
OncoDaily

Yvonne Awards 2026

Announcing the Four 2026 ASTRO Gold Medal Laureates

10 Oncology Biotech Companies (and the Scientists Behind Them) to Watch at ASCO 2026

M&A as a Precision Instrument: How an $18B+ Dealmaking Wave Is Rewiring Oncology Against the Patent Cliff

Historic ASCO and ECS Partnership Launching a New Era in Global Oncology Collaboration - ECS

Estela Rodriguez: Top Lung Cancer Abstracts at ASCO 2026

Phase 3 LAPIS Trial: Pamrevlumab Plus Chemotherapy in Locally Advanced Pancreatic Cancer

Amol Akhade: How to Avoid ASCO FOMO And Make Best of Virtual ASCO

Voices
SIOPE

Applications Are Now Open for the ERN PaedCan Twinning Programme 2026 - SIOPE

Amil Družić: Celebrating European School of Oncology Collaboration at Italian Embassy in Brussels

Amil Družić: Visiting the Italian Ambassador's Residence With European School of Oncology's CEO

Muna Al-Khaifi: A Chronic Disease Model of Care for Cancer Survivorship

Translating Complex Tumour Biology Into Everyday Clinical Care - SPCC

Estelamari Rodriguez: ASCO26 Schedule for Those Who Are Interested in Thoracic Oncology

Mark Lawler: €55.6 Million Investment in All-Island Research Collaboration and Cancer Impact

FDA Approvals
Decnupaz

FDA Approves Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

BTOG (British Thoracic Oncology Group) National Trials Meeting 2026

British Thoracic Oncology Group

22 Jul
British Thoracic Oncology Group

SPCC (Sharing Progress in Cancer Care) Webinar - HER2DX: Translating Biology into Care

Sharing Progress in Cancer Care

16 Jun
SPCC

MASCC Webinar: The Role of Biosimilars in Expanding Access and Sustainability

MASCC

11 Jun
MASCC

ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

GI Cancers Alliance

09 Jun
ASCO 2026: Key Highlights for Stomach/Gastric Cancer Patients

Geriatric Oncology: Cognition and Communication 2026 - MSKCC

Memorial Sloan Kettering Cancer Center

28 May
Geriatric Oncology

Immune-oncology
PD-(L)1 Rechallenge After Immunotherapy Resistance in Advanced NSCLC

PD-(L)1 Rechallenge After Immunotherapy Resistance in Advanced NSCLC

DELII trial: Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors

Overcoming Primary and Acquired Resistance to Immunotherapy in NSCLC

NIVOTAX Trial: Paclitaxel Plus Nivolumab in Cisplatin-Ineligible Head and Neck Cancer

Polish–Czech Real-World Analysis of Cemiplimab Immune Toxicities in Cervical Cancer

Asthma Drug Enhances Immunotherapy Response in Resistant Cancers

Camrelizumab Plus Apatinib in Refractory Chordoma: A Phase II Clinical Trial

Gastrointestinal-Oncology
LAPIS Trial

Phase 3 LAPIS Trial: Pamrevlumab Plus Chemotherapy in Locally Advanced Pancreatic Cancer

10 Must-Read Posts In GI Oncology This Week

EBRT in Hepatocellular Carcinoma: Multinational Data Support Its Role in Early-Stage Disease

Breaking the Undruggable: KRAS G12D Inhibition and the Emerging Era of Precision Oncology in PDAC

IMbrave050 Updates: Adjuvant Atezolizumab Plus Bevacizumab in High-Risk HCC

Top Colorectal Cancer Trials to Watch at ASCO 2026

10 Must-Read Posts In GI Oncology This Week

Breast-Oncology
HER2-Positive Breast Cancer

HER2-Positive Breast Cancer: From Fear to a Story of Hope

Dato-DXd Plus Durvalumab Shows Durable First-Line Activity in Advanced TNBC

NeoTRIPaPDL1 Transcriptomic Analysis Reveals Early Predictors of Response in TNBC

TQB2102 Shows Early Activity Across HER2-Expressing Solid Tumors

OLIGOMA Trial: SBRT Extends PFS in Oligometastatic Breast Cancer

Chest Wall Perforator Flaps in Breast Cancer Surgery: What the Evidence Shows So Far

FDA Approves T-DXd for Two Early HER2-Positive Breast Cancer Settings

Lung-Oncology
Proton Therapy

Proton Therapy vs IMRT in Locally Advanced NSCLC: Long-Term Results Show Similar Lung Toxicity, With A Cardiac Signal Favoring Proton Therapy

DESTINY-Lung03: T-DXd Confirms Activity in HER2-Overexpressing NSCLC, but Triplet Therapy Falls Short

Henlius Advances HLX43 Phase 2 Trial in NSCLC With First EU Patient Dosed

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

PD-(L)1 Blockade in Never-Smokers With AGA-Negative NSCLC: What the Data Show

Tumor-Naïve ctDNA Testing May Refine Risk in Early-Stage NSCLC

Second-Event Endpoints After Anti–PD-(L)1 Therapy: Are We Measuring Immunotherapy Benefit the Right Way?

OncoDaily TV
How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Hisham Mehanna

What It Takes to Lead in Oncology Prof. Hisham Mehanna on Research, Mentorship & Life Balance

ASCO

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Empowering Oncologists: Why Survivorship Matters?

Empowering Oncologists: Why Survivorship Matters?

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Professor Richard Sullivan: Building Cancer Systems Amidst Global Instability

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Fixing the Broken Link Between Patients and Cancer Care in Developing Countries: Dr. Emad Shash

Not To Miss
IARC60

20 Posts Not To Miss From IARC60 Conference

25 Posts Not To Miss From WHA79

Highlights From How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

20 Posts Not To Miss From AUA26: American Urological Association Annual Meeting

King Hussein Cancer Research Award: Advancing Cancer Research Across the Arab World 2026

10 Must-Read Posts In GU Oncology This Week

10 Must-Read Posts In GI Oncology This Week

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
CLL-RT

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

CancerWorld

Oncologists
Sara Tolaney

Sara Tolaney

Oncologists Location Boston, USA
Florian Lordick

Florian Lordick

Oncologists Location Leipzig, Germany
Ilaria Colombo

Ilaria Colombo

Oncologists Location Bellinzona, Switzerland
Salvatore Provenzano

Salvatore Provenzano

Oncologists Location Milan, Italy
Leo Mascarenhas

Leo Mascarenhas

Oncologists Location Los Angeles, USA
Luiz H. de Lima Araujo

Luiz H. de Lima Araujo

Oncologists Location Rio de Janeiro, Brazil
Zainab Shinkafi-Bagudu

Zainab Shinkafi-Bagudu

Oncologists Location Abuja, Nigeria
Juliet Lumati

Juliet Lumati

Oncologists Location Illinois, USA

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

OncoDaily Medical Journal

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research